Aier Eye Hospital Group Co., Ltd.
300015
Rangering i aksjer
#1909
Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic... Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic healthcare services and institutions. Its comprehensive medical offerings encompass specialties such as the diagnosis and treatment of fundus diseases, optometry, refractive correction, glaucoma, corneal conditions, and cataracts. Beyond direct patient care, the company also conducts training courses focused on cataract prevention and management. The group boasts an extensive international footprint, operating approximately 500 ophthalmic facilities across mainland China, with additional presences including 86 in Europe, 1 in the United States, 7 in Hong Kong, and 12 throughout Southeast Asia. Founded in 2007, Aier Eye Hospital Group maintains its headquarters in Changsha, China.
Aksjekurs
$1.19
Markedsverdi
$11.08B
Endring (1 dag)
3.59%
Endring (1 år)
-31.15%
Land
CN
Handel Aier Eye Hospital Group Co., Ltd. (300015)
Kategori
Healthcare
Antall utestående aksjer for Aier Eye Hospital Group Co., Ltd. (300015)
Antall utestående aksjer per June 2026: 9.29B
Ifølge Aier Eye Hospital Group Co., Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 9.29B. Ved slutten av December 2023 hadde selskapet 9.25B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Aier Eye Hospital Group Co., Ltd. (300015) fra 2006 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 9.29B | 0.47% |
| 2024 | 9.24B | -0.07% |
| 2023 | 9.25B | 2.10% |
| 2022 | 9.06B | 0.07% |
| 2021 | 9.05B | 1.48% |
| 2020 | 8.92B | 1.39% |
| 2019 | 8.80B | -0.05% |
| 2018 | 8.80B | 2.80% |
| 2017 | 8.56B | 2.25% |
| 2016 | 8.38B | 0.97% |
| 2015 | 8.30B | 3.03% |
| 2014 | 8.05B | -0.57% |
| 2013 | 8.10B | 1.17% |
| 2012 | 8.00B | 29.35% |
| 2011 | 6.19B | 0.03% |
| 2010 | 6.19B | 27.76% |
| 2009 | 4.84B | 4.47% |
| 2008 | 4.63B | 5.82% |
| 2007 | 4.38B | 4.25% |
| 2006 | 4.20B | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 222.83M | -97.60% |
US
|
|
| - | - |
DE
|
|
| 83.52M | -99.10% |
US
|
|
| 350.00M | -96.23% |
SA
|
|
| 2.18B | -76.52% |
BR
|
